Brief by Shorts91 Newsdesk / 11:21am on 03 Sep 2026,Thursday Business
India’s largest drugmaker, Sun Pharmaceutical Industries, has signed an agreement with the US government to make medicines more affordable for American patients. The Mumbai-based company will offer “Most Favoured Nation” pricing to US state Medicaid programmes, providing medicines at the lowest prices offered in other developed countries. The arrangement will also apply to Sun Pharma’s future innovative medicines in the US market. The agreement was part of a wider US government push to lower prescription drug prices. In return, the company has secured a delay of more than two years in proposed Section 232 tariffs on its innovative pharmaceutical products. (PC: HT)
